Piraeus Medical has announced the US launch of the 6Fr 70 NeuGlide catheter alongside first clinical cases utilising the ...

Acandis has announced the completion of its merger with Angionautix—a Spain- and Latin America-based neurovascular ...

Route 92 Medical today announced US Food and Drug Administration 510(k) clearance for the FreeClimb 46 catheter with Tenzing ...

Vital3D Technologies—a Lithuanian deep-tech company developing precision 3D microfabrication technology for medical devices, ...

Baystate Health (Springfield, USA) has announced it was previously selected to participate in a clinical trial intended to ...

Perfuze has announced the publication of a peer-reviewed study in Clinical Neuroradiology comparing three aspiration ...

Anaconda Biomed today announced the closing of a US$56 million financing round with participation from new and existing investors. Proceeds will support product development and clinical work, ...

As the stroke community continues to construct a greater understanding of the various factors that influence patient outcomes, many have called for more nuanced alternatives to the modified Rankin ...

Subsense—an artificial intelligence (AI)-native neurotechnology company developing non-surgical, nanoparticle-based brain-computer interfaces (BCIs)—has announced a major expansion of its AI-driven ...

Cercare Medical has announced an educational collaboration with the European Society of Neuroradiology (ESNR) in support of Perfusion Summit 2027 (29–30 April, Milan, Italy)—the company’s flagship ...

Despite markedly reducing chronic subdural haematoma (cSDH) recurrence without significantly increasing overall adverse events, adjunctive middle meningeal artery embolisation (MMAE) was not ...

Despite markedly reducing chronic subdural haematoma (cSDH) recurrence without significantly increasing overall adverse events, adjunctive middle meningeal artery embolisation (MMAE) was not ...